Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DEPAKENE
- Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy
- Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric Migraine
- Cost- Effectiveness and Quality of Life Assessment in Mood Disorder
- Chemoprevention of Head and Neck Squamous Cell Carcinoma (HNSCC) With Valproic Acid
- Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer
- Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter
- Haloperidol vs. Valproate in Agitation
- Phase II 5-Azacytidine Plus VPA Plus ATRA
- Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
- Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
- Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas
- Adjuvant Valproate for High Grade Sarcomas
- Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma
- Valproic Acid and Bevacizumab in Patients With Advanced Cancer
- Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer
- Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases
- Azacytidine and Valproic Acid in Patients With Advanced Cancers
- Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
- Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients
- Phase II 5-Azacytidine Plus VPA Plus ATRA
- Decitabine With or Without Valproic Acid in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer
- Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trials list
click for details